Garnier M - Search Results

1

Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent.

Meijer L, Thunnissen AM, White AW, Garnier M, Nikolic M, Tsai LH, Walter J, Cleverley KE, Salinas PC, Wu YZ, Biernat J, Mandelkow EM, Kim SH, Pettit GR. Meijer L, et al. Among authors: garnier m. Chem Biol. 2000 Jan;7(1):51-63. doi: 10.1016/s1074-5521(00)00063-6. Chem Biol. 2000. PMID: 10662688

2

Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?

Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernat J, Wu YZ, Mandelkow EM, Eisenbrand G, Meijer L. Leclerc S, et al. Among authors: garnier m. J Biol Chem. 2001 Jan 5;276(1):251-60. doi: 10.1074/jbc.M002466200. J Biol Chem. 2001. PMID: 11013232 Free article.

3

Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1.

Jeong HW, Kim MR, Son KH, Han MY, Ha JH, Garnier M, Meijer L, Kwon BM. Jeong HW, et al. Among authors: garnier m. Bioorg Med Chem Lett. 2000 Aug 21;10(16):1819-22. doi: 10.1016/s0960-894x(00)00357-7. Bioorg Med Chem Lett. 2000. PMID: 10969976

4

Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects.

Mettey Y, Gompel M, Thomas V, Garnier M, Leost M, Ceballos-Picot I, Noble M, Endicott J, Vierfond JM, Meijer L. Mettey Y, et al. Among authors: garnier m. J Med Chem. 2003 Jan 16;46(2):222-36. doi: 10.1021/jm020319p. J Med Chem. 2003. PMID: 12519061

5

Imidazo[2,1 -b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition.

Andreani A, Cavalli A, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Recanatini M, Garnier M, Meijer L. Andreani A, et al. Among authors: garnier m. Anticancer Drug Des. 2000 Dec;15(6):447-52. Anticancer Drug Des. 2000. PMID: 11716438

6

The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line.

Garnier M, Boujrad N, Ogwuegbu SO, Hudson JR Jr, Papadopoulos V. Garnier M, et al. J Biol Chem. 1994 Sep 2;269(35):22105-12. J Biol Chem. 1994. PMID: 8071335 Free article.

7

Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line.

Papadopoulos V, Amri H, Li H, Boujrad N, Vidic B, Garnier M. Papadopoulos V, et al. Among authors: garnier m. J Biol Chem. 1997 Dec 19;272(51):32129-35. doi: 10.1074/jbc.272.51.32129. J Biol Chem. 1997. PMID: 9405411 Free article.

8

Identification of a stimulator of steroid hormone synthesis isolated from testis.

Boujrad N, Ogwuegbu SO, Garnier M, Lee CH, Martin BM, Papadopoulos V. Boujrad N, et al. Among authors: garnier m. Science. 1995 Jun 16;268(5217):1609-12. doi: 10.1126/science.7777858. Science. 1995. PMID: 7777858

9

Acute action of choriogonadotropin on Leydig tumor cells: induction of a higher affinity benzodiazepine-binding site related to steroid biosynthesis.

Boujrad N, Gaillard JL, Garnier M, Papadopoulos V. Boujrad N, et al. Among authors: garnier m. Endocrinology. 1994 Oct;135(4):1576-83. doi: 10.1210/endo.135.4.7925120. Endocrinology. 1994. PMID: 7925120

10

In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.

Garnier M, Dimchev AB, Boujrad N, Price JM, Musto NA, Papadopoulos V. Garnier M, et al. Mol Pharmacol. 1994 Feb;45(2):201-11. Mol Pharmacol. 1994. PMID: 8114671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page